Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Scleroderma Cardiovascular Diseases Connective Tissue Diseases Hypertension Hypertension, Pulmonary Lung Diseases Pulmonary Hypertension Respiratory Tract Diseases Scleroderma, Diffuse Scleroderma, Systemic Skin Diseases Skin and Connective Tissue Diseases Vascular Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

About this study

As above

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient must have Scleroderma

Exclusion criteria

Patients who do not have Scleroderma

Sponsors and collaborators

Lead sponsor

Northwell Health

Other

Registry information

Acronym: Scleroderma

Important dates

Study start: 2006
Study completion: 2007
First posted: Dec 3, 2007
Registry last updated: Mar 9, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed